Trial Profile
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Safety and Efficacy of SC-07 for the Delay to Onset of Severe Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Golotimod (Primary)
- Indications Mucositis
- Focus Adverse reactions; Therapeutic Use
- Sponsors SciClone Pharmaceuticals
- 25 Sep 2014 New trial record